Topics:

ubmslateCL-logo-ubm

CL Mobile Menu

Diabetes Type 2

SGLT2 Inhibitor Q & A

Four questions for you to answer, four facts you need to know.

 

Diabetes Type 2

The good news is that a few diabetes drugs now show valid cardioprotective benefits; the bad news is the drugs are unaffordable for many.

Results of the intensive 12-week intervention included a significant drop in healthcare utilization, missed work days, and A1c levels.

New findings and guidelines translate into better awareness, understanding, and clinical decision making.

What specific symptoms might be more likely in children with a family history of MI vs those with a history of diabetes?

FDA is requiring a class labeling change that will allow many more diabetes patients to benefit from metformin.

This short slideshow highlights four new studies on eating habits that demonstrate how diet may affect patients’ health.

© ChameleonsEye/Shutterstock.com

And the parameters of hypoxemia may be more sensitive than the apnea–hypopnea index.

Pages

Subscribe to Diabetes Type 2 on [sitename]

By clicking Accept, you agree to become a member of the UBM Medica Community.